The Classics in Medicine™: Summaries of the Landmark Trials
Online Edition | All Specialties
Print ISBN 978-0-9963042-9-0| E-book ISBN 978-0-9963042-1-4 | © 2021 2 Minute Medicine, Inc. | Boston, MA | Search Directory
Unlimited Ad-free Reading for Subscribers | Institutional Access
The Classics in Medicine™ | Summaries of the Landmark Trials | Online Edition
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics Series]
1. The Child-Pugh score consists of five clinical features and is used to assess the prognosis of chronic liver disease and cirrhosis. 2. The Child-Pugh score was originally developed in 1973 to predict surgical outcomes in patients...
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
1. The ABCD2 score is a validated, seven-point, risk-stratification tool to identify patients at high risk of stroke following a transient ischemic attack (TIA). 2. Patients with scores ≥4 are at considerably higher risk of stroke in...
The ORACLE trial: Antibiotics for preterm, prelabor rupture of membranes [Classics Series]
1. Among infants born to women with preterm, premature rupture of membranes, those whose mothers were randomized to treatment with erythromycin experienced a lower incidence of adverse neonatal outcomes and prolongation of pregnancy compared to the placebo...
The Lee index: Risk of perioperative cardiac events [Classics Series]
1. The Lee index is a prospectively validated model that predicts the risk of a cardiac event in patients undergoing noncardiac surgery. 2. The six independent predictors are as follows: 1) high-risk surgery, 2) history of ischemic...
The DOSE trial: Loop diuretic strategies in acute decompensated heart failure [Classics Series]
1. The use of loop diuretics in acute decompensated heart failure is commonplace, but clinical practice varies widely with regards to the dosage and administration of therapy. 2. This study found that mode of administration (bolus vs. continuous...
The NICE-SUGAR trial: Intensive glycemic control harmful in the ICU [Classics Series]
1. Intensive glycemic control in critically ill patients significantly increases 90-day mortality when compared to conventional glycemic control. 2. The incidence of severe hypoglycemia was significantly higher in patients receiving intensive glycemic control. Original Date of Publication:...
Fleischner Society Guidelines, 2017 Update: Consolidated follow-up recommendations for incidental solid and subsolid pulmonary nodules [Classics Series]
The following study summary is an excerpt from the book 2 Minute Medicine's The Classics in Radiology: Summaries of Clinically Relevant & Recent Landmark Studies, 1e (The Classics Series). 1. The revised Fleischner Society Guidelines (Tables I and...
The ACCORD trial: Intensive glucose control associated with increased mortality [Classics Series]
1. Previous studies suggest that intensive blood glucose control reduces the risk of microvascular complications, though questions remained regarding the impact on macrovascular complications and mortality. 2. This study found that targeting HbA1c <6.0% resulted in higher...
The Wells DVT criteria: Clinical prediction model for deep vein thrombosis [Classics Series]
1. The Wells DVT criteria are a validated clinical model for estimating pre-test probability of DVT. 2. D-dimer testing in outpatients can help inform the need for venous ultrasonography in the diagnosis of DVT. Original Date of...
The ARMA trial: Lower tidal volume ventilation in ALI/ARDS [Classics Series]
1. The trial was terminated early when the data demonstrated that lower tidal volume ventilator settings in ALI/ARDS patients led to a significant decrease in in-hospital mortality. 2. Low tidal volume ventilation also led to an increase...
The PROSEVA trial: Proning in severe ARDS [Classics Series]
1. In patients with severe acute respiratory distress syndrome (ARDS), prone-positioning significantly reduced 28-day and 90-day mortality when compared with patients remaining in supine position. 2. Proned patients were also successfully extubated at higher rates and required...
The RALES trial: Spironolactone decreases all-cause mortality in heart failure patients [Classics Series]
Image: PD 1. Adding 25 mg of spironolactone to standard therapy reduces all-cause mortality in heart failure patients with an ejection fraction <35% Original Date of Publication: September 2, 1999 Study Rundown: This landmark study supported the use...
The POISE trial: Perioperative use of beta-blockers [Classics Series]
1. The POISE trial was a randomized controlled trial exploring the effect of perioperative beta-blockers on cardiac death, nonfatal myocardial infarctions, and nonfatal cardiac arrest. 2. Perioperative oral extended-release metoprolol was found to reduce the risk of...
The SOAP-II trial: First-line vasopressor for shock management [Classics Series]
Image: PD 1. There were no significant differences in 28-day, 6-month, or 12-month mortality when comparing dopamine and norepinephrine as first-line vasopressors in managing shock. 2. Dopamine was associated with a significantly higher rate of arrhythmias, as...
The AMPLIFY trial: Apixaban for treatment of venous thromboembolism [Classics Series]
1. Apixaban was found to be non-inferior to conventional therapy (i.e., enoxaparin followed by warfarin) in the treatment of acute venous thromboembolism. 2. Major bleeding was found to be significantly less common in patients treated with apixaban...